Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: Clinical significance
Open Access
- 8 September 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 126 (8), 1828-1837
- https://doi.org/10.1002/ijc.24879
Abstract
This study focused on a cell cycle regulatory gene, FBXW7, which ubiquitinates c-Myc and cyclin E and promotes exit from the cell cycle. We determined the expression level of FBXW7 in colorectal cancer (CRC) cases, correlated those values with clinicopathologic features, and characterized the molecular mechanism of reduced expression of FBXW7 in CRC cells in vitro. FBXW7 mRNA and protein expression were evaluated in 93 CRC cases. Using CGH array, the copy number aberrations of the flanking region of FBXW7 were evaluated in another 130 CRC specimens. In vitro analysis of FBXW7 gene silencing in CRC cells was conducted. FBXW7 mRNA expression was significantly lower in tumor tissues than the corresponding normal tissues. The low FBXW7 expression group showed a significantly poorer prognosis than patients in the high expression group. A concordant relationship was observed between the incidence of FBXW7 repression and the genetic alteration. The incidence of genetic alteration was associated with the stage of disease progression. In vitro, FBXW7-specific siRNA enhanced expression of c-MYC and cyclin E proteins and up-regulated cell proliferation. Genetic alterations in tumors led to the loss of FBXW7 expression and increased cell proliferation. FBXW7 expression provides a prognostic factor for patients with CRC.Funding Information
- CREST, Japan Science and Technology Agency (JST) and Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (17109013, 18659384, 18390367, 18590333, 18015039, 19591509, 19390336, 20390360, 20591547, 20790961, 20790960)
- The Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-Aid for Scientific Research on Priority Areas (18015039)
- Third Term Comprehensive Ten-year Strategy for Cancer Control (16271201)
- New Energy and Industrial Technology Development Organization (NEDO) Technological Development for Chromosome Analysis
This publication has 23 references indexed in Scilit:
- The methylation status of FBXW7 β-form correlates with histological subtype in human thymomaBiochemical and Biophysical Research Communications, 2008
- FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiationNature Reviews Cancer, 2008
- Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesisThe Journal of Experimental Medicine, 2007
- FBXW7/hCDC4 Is a General Tumor Suppressor in Human CancerCancer Research, 2007
- Mutational and LOH Analyses of the Chromosome 4q Region in Esophageal AdenocarcinomaOncology, 2006
- CDC4 Mutations Occur in a Subset of Colorectal Cancers but Are Not Predicted to Cause Loss of Function and Are Not Associated with Chromosomal InstabilityCancer Research, 2005
- Clinical Significance of Human Kallikrein Gene 6 Messenger RNA Expression in Colorectal CancerClinical Cancer Research, 2005
- Screening of DNA copy‐number aberrations in gastric cancer cell lines by array‐based comparative genomic hybridizationCancer Science, 2005
- A gene-expression signature can quantify the degree of hepatic fibrosis in the ratJournal of Hepatology, 2004
- Microarray data normalization and transformationNature Genetics, 2002